FDA panel votes against Novo Nordisk's weekly insulin in type 1 diabetes patients – CNBC

Advisers to the U.S. health regulator on Friday voted against the use of Novo Nordisk's weekly insulin in patients with type 1 diabetes due to …

scroll to top